S. Esmail Tabibi

574 total citations
23 papers, 472 citations indexed

About

S. Esmail Tabibi is a scholar working on Pharmaceutical Science, Molecular Biology and Spectroscopy. According to data from OpenAlex, S. Esmail Tabibi has authored 23 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 6 papers in Spectroscopy. Recurrent topics in S. Esmail Tabibi's work include Drug Solubulity and Delivery Systems (8 papers), Analytical Chemistry and Chromatography (6 papers) and Crystallization and Solubility Studies (6 papers). S. Esmail Tabibi is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), Analytical Chemistry and Chromatography (6 papers) and Crystallization and Solubility Studies (6 papers). S. Esmail Tabibi collaborates with scholars based in United States, China and Malaysia. S. Esmail Tabibi's co-authors include Samuel H. Yalkowsky, Ping Li, Zheng‐Rong Lu, Nina Ni, Jindřich Kopeček, Ping Li, Yuko Kasuya, Pavla Kopečková, Tamara Minko and Yan He and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

S. Esmail Tabibi

23 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Esmail Tabibi United States 12 213 143 141 114 71 23 472
Peter Hölig Germany 8 349 1.6× 141 1.0× 191 1.4× 58 0.5× 76 1.1× 10 565
J.D. Pipkin United States 16 209 1.0× 67 0.5× 175 1.2× 41 0.4× 39 0.5× 34 529
Eduardo Jule Denmark 9 473 2.2× 127 0.9× 150 1.1× 111 1.0× 112 1.6× 10 712
Nathaniel D. Catron United States 6 274 1.3× 165 1.2× 89 0.6× 57 0.5× 28 0.4× 7 400
Bernd Riebesehl Switzerland 8 122 0.6× 47 0.3× 127 0.9× 96 0.8× 76 1.1× 8 402
Kentaro Furumoto Japan 11 241 1.1× 139 1.0× 215 1.5× 37 0.3× 276 3.9× 11 642
Morton Rosoff United States 11 100 0.5× 75 0.5× 195 1.4× 53 0.5× 48 0.7× 16 437
Vincent Plassat France 7 117 0.5× 55 0.4× 130 0.9× 37 0.3× 134 1.9× 7 356
Silvia Mazzaferro France 12 221 1.0× 60 0.4× 186 1.3× 36 0.3× 221 3.1× 14 529
Ralph Lipp Germany 12 277 1.3× 48 0.3× 116 0.8× 26 0.2× 26 0.4× 27 487

Countries citing papers authored by S. Esmail Tabibi

Since Specialization
Citations

This map shows the geographic impact of S. Esmail Tabibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Esmail Tabibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Esmail Tabibi more than expected).

Fields of papers citing papers by S. Esmail Tabibi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Esmail Tabibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Esmail Tabibi. The network helps show where S. Esmail Tabibi may publish in the future.

Co-authorship network of co-authors of S. Esmail Tabibi

This figure shows the co-authorship network connecting the top 25 collaborators of S. Esmail Tabibi. A scholar is included among the top collaborators of S. Esmail Tabibi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Esmail Tabibi. S. Esmail Tabibi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gardner, Erin R., et al.. (2012). Preformulation Study of NSC-726796. AAPS PharmSciTech. 13(2). 661–673. 1 indexed citations
2.
Myrdal, Paul B., et al.. (2010). Stability of 5-Fluoro-2′-deoxycytidine and Tetrahydrouridine in Combination. AAPS PharmSciTech. 11(1). 247–252. 9 indexed citations
3.
Sanghvi, Ritesh, Erik Mogalian, Stephen G. Machatha, et al.. (2008). Preformulation and pharmacokinetic studies on antalarmin: A novel stress inhibitor. Journal of Pharmaceutical Sciences. 98(1). 205–214. 11 indexed citations
4.
Machatha, Stephen G., et al.. (2007). Degradation kinetics and mechanism of RH1, a new anti-tumor agent: A technical note. AAPS PharmSciTech. 8(1). E113–E117. 4 indexed citations
5.
He, Yan, S. Esmail Tabibi, & Samuel H. Yalkowsky. (2005). Solubilization of two structurally related anticancer drugs: XK-469 and PPA. Journal of Pharmaceutical Sciences. 95(1). 97–107. 17 indexed citations
6.
Lu, Zheng‐Rong, et al.. (2002). Influence of the Structure of Drug Moieties on the in Vitro Efficacy of HPMA Copolymer–Geldanamycin Derivative Conjugates. Pharmaceutical Research. 19(2). 115–123. 26 indexed citations
7.
Ni, Nina, et al.. (2001). Use of pure t-butanol as a solvent for freeze-drying: a case study. International Journal of Pharmaceutics. 226(1-2). 39–46. 55 indexed citations
8.
Tabibi, S. Esmail, et al.. (2001). Solubilization of NSC-639829. International Journal of Pharmaceutics. 225(1-2). 41–47. 27 indexed citations
9.
Pinsuwan, Sirirat, Fernando Alvarez‐Núñez, S. Esmail Tabibi, & Samuel H. Yalkowsky. (1999). Spectrophotometric determination of acidity constants of 4‐dedimethylamino sancycline (Col‐3), a new antitumor drug. Journal of Pharmaceutical Sciences. 88(5). 535–537. 17 indexed citations
10.
Li, Ping, S. Esmail Tabibi, & Samuel H. Yalkowsky. (1999). Solubilization of ionized and un‐ionized flavopiridol by ethanol and polysorbate 20. Journal of Pharmaceutical Sciences. 88(5). 507–509. 36 indexed citations
11.
Li, Ping, S. Esmail Tabibi, & Samuel H. Yalkowsky. (1999). Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. Journal of Pharmaceutical Sciences. 88(9). 945–947. 52 indexed citations
12.
Tabibi, S. Esmail, et al.. (1998). Mechanism of dansylation of the polyamine pentaazapentacosane ·5 HCl. International Journal of Pharmaceutics. 160(1). 21–29. 3 indexed citations
13.
Tabibi, S. Esmail, et al.. (1998). combined effect of complexation and pH on solubilization. Journal of Pharmaceutical Sciences. 87(12). 1535–1537. 72 indexed citations
14.
Li, Ping, et al.. (1998). Evaluation of in Vitro Precipitation Methods. Journal of Pharmaceutical Sciences. 87(2). 196–199. 23 indexed citations
15.
Simamora, Pahala, et al.. (1998). Emulsion formulations for intravenous administration of paclitaxel.. PubMed. 52(4). 170–2. 17 indexed citations
16.
Tabibi, S. Esmail, et al.. (1997). Derivatization and high-performance liquid chromatographic analysis of pentaazapentacosane pentahydrochloride. Journal of Chromatography B Biomedical Sciences and Applications. 691(1). 173–178. 5 indexed citations
17.
Phillips, Lawrence R., et al.. (1997). Analysis of perillic acid in plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 688(2). 354–358. 10 indexed citations
18.
Dannenfelser, Rose‐Marie, et al.. (1997). Parenteral formulation of Flavopiridol (NSC-649890).. PubMed. 50(6). 356–9. 11 indexed citations
19.
20.
Tabibi, S. Esmail, et al.. (1984). Interaction of water vapor and compressible sugar. International Journal of Pharmaceutics. 18(1-2). 169–183. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hölig Breakdown of academic impact, for papers by J.D. Pipkin Breakdown of academic impact, for papers by Eduardo Jule Breakdown of academic impact, for papers by Nathaniel D. Catron Breakdown of academic impact, for papers by Bernd Riebesehl Breakdown of academic impact, for papers by Kentaro Furumoto Breakdown of academic impact, for papers by Morton Rosoff Breakdown of academic impact, for papers by Vincent Plassat Breakdown of academic impact, for papers by Silvia Mazzaferro Breakdown of academic impact, for papers by Ralph Lipp
Rankless by CCL
2026